Cooper Companies, Inc. (The) (NYSE:COO) Rating Reiterated by KeyCorp

Cooper Companies, Inc. (The) (NYSE:COO)‘s stock had its “hold” rating reiterated by KeyCorp in a research note issued to investors on Friday, October 20th.

Several other equities research analysts have also recently issued reports on the company. Robert W. Baird set a $273.00 price objective on Cooper Companies, Inc. (The) and gave the stock a “buy” rating in a report on Monday, October 16th. BMO Capital Markets reiterated a “buy” rating and issued a $272.00 target price on shares of Cooper Companies, Inc. (The) in a report on Friday, October 13th. Zacks Investment Research upgraded Cooper Companies, Inc. (The) from a “hold” rating to a “buy” rating and set a $265.00 target price on the stock in a report on Tuesday, October 10th. Jefferies Group LLC reissued a “buy” rating and issued a $250.00 price objective on shares of Cooper Companies, Inc. (The) in a research report on Tuesday, September 12th. Finally, Stephens reissued an “equal weight” rating and issued a $250.00 price objective (up from $235.00) on shares of Cooper Companies, Inc. (The) in a research report on Tuesday, September 12th. Six equities research analysts have rated the stock with a hold rating and eight have assigned a buy rating to the stock. The company has an average rating of “Buy” and an average price target of $261.11.

Shares of Cooper Companies, Inc. (NYSE COO) opened at 244.43 on Friday. The company’s 50-day moving average price is $239.81 and its 200 day moving average price is $233.35. The stock has a market cap of $11.96 billion, a price-to-earnings ratio of 35.05 and a beta of 0.54. Cooper Companies, Inc. has a 12-month low of $158.73 and a 12-month high of $256.39.

Cooper Companies, Inc. (The) (NYSE:COO) last announced its earnings results on Thursday, August 31st. The medical device company reported $2.64 EPS for the quarter, beating analysts’ consensus estimates of $2.58 by $0.06. Cooper Companies, Inc. (The) had a return on equity of 16.00% and a net margin of 16.45%. The firm had revenue of $556.00 million for the quarter, compared to analysts’ expectations of $552.32 million. During the same quarter in the prior year, the firm earned $2.30 EPS. Cooper Companies, Inc. (The)’s quarterly revenue was up 8.0% on a year-over-year basis. On average, equities analysts predict that Cooper Companies, Inc. will post $9.73 earnings per share for the current year.

ILLEGAL ACTIVITY NOTICE: This story was published by Dispatch Tribunal and is the sole property of of Dispatch Tribunal. If you are reading this story on another site, it was copied illegally and reposted in violation of U.S. and international copyright law. The legal version of this story can be read at https://www.dispatchtribunal.com/2017/10/29/keycorp-reaffirms-hold-rating-for-cooper-companies-inc-the-coo.html.

In related news, Director Gary S. Petersmeyer sold 3,977 shares of the business’s stock in a transaction that occurred on Thursday, September 14th. The stock was sold at an average price of $244.94, for a total transaction of $974,126.38. The sale was disclosed in a legal filing with the SEC, which is available at this hyperlink. Insiders own 1.60% of the company’s stock.

A number of large investors have recently made changes to their positions in the stock. Vanguard Group Inc. raised its holdings in Cooper Companies, Inc. (The) by 3.3% during the second quarter. Vanguard Group Inc. now owns 4,938,181 shares of the medical device company’s stock worth $1,182,298,000 after purchasing an additional 156,449 shares in the last quarter. BlackRock Inc. increased its holdings in shares of Cooper Companies, Inc. (The) by 4.5% in the second quarter. BlackRock Inc. now owns 3,210,032 shares of the medical device company’s stock valued at $768,546,000 after buying an additional 138,395 shares in the last quarter. Janus Henderson Group PLC increased its holdings in shares of Cooper Companies, Inc. (The) by 558.5% in the second quarter. Janus Henderson Group PLC now owns 2,175,791 shares of the medical device company’s stock valued at $520,937,000 after buying an additional 1,845,368 shares in the last quarter. Pioneer Investment Management Inc. increased its holdings in shares of Cooper Companies, Inc. (The) by 136.6% in the second quarter. Pioneer Investment Management Inc. now owns 1,226,250 shares of the medical device company’s stock valued at $293,589,000 after buying an additional 708,028 shares in the last quarter. Finally, Bessemer Group Inc. increased its holdings in shares of Cooper Companies, Inc. (The) by 39.1% in the second quarter. Bessemer Group Inc. now owns 575,951 shares of the medical device company’s stock valued at $137,895,000 after buying an additional 161,772 shares in the last quarter. 96.04% of the stock is currently owned by hedge funds and other institutional investors.

Cooper Companies, Inc. (The) Company Profile

The Cooper Companies, Inc is a global medical device company. The Company operates through two business units: CooperVision, Inc and CooperSurgical, Inc CooperVision offers soft contact lenses for the vision correction market. CooperVision develops, manufactures and markets a range of single-use, two-week and monthly contact lenses.

Analyst Recommendations for Cooper Companies, Inc. (The) (NYSE:COO)

Receive News & Ratings for Cooper Companies Inc. (The) Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cooper Companies Inc. (The) and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply